Cathay Selling General Administrative from 2010 to 2024

688065 Stock   42.84  0.22  0.51%   
Cathay Biotech's Selling General Administrative is decreasing over the years with slightly volatile fluctuation. Selling General Administrative is expected to dwindle to about 83.2 M. From 2010 to 2024 Cathay Biotech Selling General Administrative quarterly data regression line had arithmetic mean of  124,759,571 and r-squared of  0.57. View All Fundamentals
 
Selling General Administrative  
First Reported
2010-12-31
Previous Quarter
103 M
Current Value
83.2 M
Quarterly Volatility
24.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cathay Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cathay Biotech's main balance sheet or income statement drivers, such as Tax Provision of 56.8 M, Net Interest Income of 134.7 M or Interest Income of 156.9 M, as well as many indicators such as . Cathay financial statements analysis is a perfect complement when working with Cathay Biotech Valuation or Volatility modules.
  
This module can also supplement various Cathay Biotech Technical models . Check out the analysis of Cathay Biotech Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.